Testicular cancer survival in Estonia: Improving but still relatively low

Acta Oncologica

Volumn 50, Issue 1, 2011, Pages 99-105

  Aareleid, Tiiu ^a   Gondos, Adam ^b   Brenner, Hermann ^b   Pokker, Helis ^c   Leppik, Krista ^d   Mägi, Margit ^a  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c North Estonian Regional Hospital   (Estonia)

^d TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONSULTATION; CONTROLLED STUDY; ESTONIA; GROUPS BY AGE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORCHIECTOMY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; SEMINOMA; TESTIS CANCER; TESTIS NONSEMINOMA CANCER;

ADULT; AGE DISTRIBUTION; AGE FACTORS; ESTONIA; EUROPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; REGISTRIES; SEMINOMA; SURVIVAL ANALYSIS; SURVIVAL RATE; TESTICULAR NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650544750     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.480981     Document Type: Article

References (23)

1. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
2. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: Survival of cancer patients diagnosed 1990 - 94 - results and commentary. Ann Oncol 2003;14(Suppl 5):v61-118. (Pubitemid 46417464)
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0, Lyon: IARCPress; 2004.
4. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. Int J Cancer 2006;118: 3099-111.
5. Aareleid T, Brenner H. Trends in cancer patient survival in Estonia before and after the transition from a Soviet republic to an open market economy. Int J Cancer 2002;102: 45-50.
6. Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG, et al. Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 2008;44:1463-75.
7. Brenner H, Gefeller O, Hakulinen T. Period analysis for ' up-to-date ' cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004;40:326-35. (Pubitemid 38121268)
8. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961;6: 101-21.
9. Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epid 2006;164:689-96. (Pubitemid 44453498)
10. Brenner H, Rachet B. Hybrid analysis for up-to-date longterm survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004;40:2494-501. (Pubitemid 39424966)
11. Brenner H, Hakulinen T. Model based hybrid analysis of cancer patient survival. Eur J Cancer 2007;43:921-7. (Pubitemid 46366697)
12. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-16. (Pubitemid 39348882)
13. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4:87-90. (Pubitemid 15142530)
14. Gondos A, Bray F, Hakulinen T, Brenner H & the EUNICE Survival Working Group. Trends in cancer survival in 11 European populations from 1990 to 2009: A model-based analysis. Ann Oncol 2009;20:564-73.
15. Spermon JR, Witjes JA, Kiemeney LA. Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor. Urology 2002;60:889-93.
16. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn- Cedermark G, Fizazi K, et al. Guidelines on testicular cancer. European Association of Urology 2009. Available from: Http://www.uroweb.org/fileadmin/tx-eauguidelines/2009/Full/ Testis-Cancer.pdf (Pubitemid 41641630)
17. Gilbert SM, Daignault S, Weizer AZ, Wei JT, Hollenbeck BK. The use of tumor markers in testis cancer in the United States: A potential quality issue. Urol Oncol 2008;26: 153-7. (Pubitemid 351288556)
18. Sohaib SA, Koh DM, Husband JE. The role of imaging in the diagnosis, staging, and management of testicular cancer. Am J Roentgenol 2008;191:387-95.
19. Agnarsson BA, Gudbjartsson T, Einarsson GV, Magnusson K, Thoroddsen A, Bergthorsson JT, et al. Testicular germ cell tumours in Iceland: A nationwide clinicopathological study. APMIS 2006;114:779-83.
20. Sant M, Aareleid T, Artioli ME, Berrino F, Coebergh JW, Colonna M, et al. Ten-year survival and risk of relapse for testicular cancer: A EUROCARE high resolution study. Eur J Cancer 2007;43:585-92. (Pubitemid 46177586)
21. Stephenson AJ, Sheinfeld J. The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol 2004;22:225-33. (Pubitemid 38950632)
22. Bernal F, Raman JD. Exploration of treatment options for the management of stage I testicular seminoma. Expert Rev Anticancer Ther 2008;8:1081-90.
23. Huddart RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther 2005;5:123-38. (Pubitemid 40287443)